Effectiveness of aromatase inhibitors and tamoxifen in reducing subsequent breast cancer

Tamoxifen (TAM) has been prescribed for decades and aromatase inhibitors (AIs) have been used since the early 2000s in preventing subsequent breast cancer. However, outside of clinical trials, the effectiveness of AIs is not established. We examined the long-term risk of subsequent breast cancer amo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Haque, Reina, Ahmed, Syed A, Fisher, Alice, Avila, Chantal C, Shi, Jiaxiao, Guo, Amy, Craig Cheetham, T, Schottinger, Joanne E
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: WILEY-VCH Verlag 2012
Gaiak:
Clinical Cancer Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3544463/
https://ncbi.nlm.nih.gov/pubmed/23342281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.37
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak